SCHEMBL1074443

SCHEMBL1074443

CC(CNc1nccc(-c2[nH]c(C(C)(C)C)nc2Br)n1)NC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL68276 0.90 BRAF (0.63) BRAF
SCHEMBL68275 0.90 BRAF (0.63) BRAF
SCHEMBL68820 0.89 BRAF (0.56) BRAF
SCHEMBL68821 0.89 BRAF (0.56) BRAF
SCHEMBL68536 0.88 BRAF (0.53) BRAF
SCHEMBL68537 0.88 BRAF (0.53) BRAF
SCHEMBL1494675 0.82 BRAF (0.53) BRAF
SCHEMBL69326 0.78 BRAF (0.54) BRAF
SCHEMBL67390 0.78 BRAF (0.54) BRAF
SCHEMBL6520303 0.77 BRAF (0.87) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2274300-A2 NOVEL HETEROCYCLIC COMPOUNDS AND USES THEROF Novartis AG (CH) 2011-01-19 EP disclosed
WO-2009115572-A2 NOVEL HETEROCYCLIC COMPOUNDS AND USES THEROF NOVARTIS AG (CH) 2009-09-24 WO disclosed